Serial tomotherapy vs. MLC-IMRT (Multileaf Collimator Intensity Modulated Radiotherapy) for simultaneous boost treatment large intracerebral lesions / Wolff, D; Abo-Madyan, Y; Dobler, B; Lohr, F; Mai, S; Polednik, M; Wenz, F. - In: ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK. - ISSN 0939-3889. - 19:1(2009), pp. 58-66. [10.1016/j.zemedi.2008.07.003]

Serial tomotherapy vs. MLC-IMRT (Multileaf Collimator Intensity Modulated Radiotherapy) for simultaneous boost treatment large intracerebral lesions

Lohr F;
2009-01-01

Abstract

Introduction: Recent data suggest that a radiosurgery boost treatment for up to three brain metastases in addition to whole brain radiotherapy (WBRT) is beneficial. Sequential treatment of multiple metastatic lesions is time-consuming and optimal normal tissue sparing is not trivial for larger metastases when separate plans are created and are only, superimposed afterwards. Sequential Tomotherapy (see image I) with noncoplanar arcs and Multi-field IMRT may streamline the process and enable easy simultaneous treatment. We compared plans for 2-3 intracerebral targets calculated with Intensity Modulated Radiotherapy (IMRT) based on treatment with MLC or sequential Tomotherapy using the Peacock-System (see image II). Treatment time was not to exceed 90 min on a linac with standart dose rate. MIMiC plans without treatment-time restrictions were created as a benchmark. Materials and methods: Calculations are based on a Siemens KD2 linac with a dose rate of 200 MU/min. Step-and-Shoot IMRT is performed with a standard MLC (2 x 29 leaves, 1 cm), serial Tomotherapy with the Multivane-Collimator MIMiC (NOMOS Inc. USA) (see image II). Treatment plans ore created with Corms 5.0. To create plans with good conformity we chose a noncoplanar beam- and arc geometry for each approach (IMRT 4-, MIMiC 5-couch angles). The benchmark MIMiC plans with maximally steep (lose gradients had 9 couch angles. For plan comparison reasons, 10Gy were prescribed to 90% of the PTV. Steepness of (lose gradients, homogeneity and conformity were assessed by the following parameters: Volume encompassed by certain isodoses outside the target as well as homogeneity and conformity as indicated by Homogeneity- and Conformity-Index. Results: Plans without treatment-time restrictions had slightest close to organ at risk (OAR), normal tissue and least Conformity-index. MIMiC- and MLC-IMRT based plans can be treated within the intended period of 90 mill, all plans met the required close (see Table 2). MLC based plans resulted ill higher (lose to organs at risk (OAR) (see table 1) and close to tissue outside the targets (see table 3), (is indicated by a higher CI (see image III). The HI was similar for all calculated plans (see image IV). Discussion: When treatment plans resulting in a similar treatment time were compared, serial Tomotherapy showed minor advantages over MLC based IMRT with regard to conformity, OAR sparing, and steepness of dose gradients. Both methods are inferior to serial Tomotherapy with ideal plan quality disregarding treatment efficiency. Treating multiple metastases ill less than 1 h would therefore be possible on a LINAC with high dose rate and bidirectional rotation with minor compromises oil gradient sleepless.
2009
1
Wolff, D; Abo-Madyan, Y; Dobler, B; Lohr, F; Mai, S; Polednik, M; Wenz, F
Serial tomotherapy vs. MLC-IMRT (Multileaf Collimator Intensity Modulated Radiotherapy) for simultaneous boost treatment large intracerebral lesions / Wolff, D; Abo-Madyan, Y; Dobler, B; Lohr, F; Mai, S; Polednik, M; Wenz, F. - In: ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK. - ISSN 0939-3889. - 19:1(2009), pp. 58-66. [10.1016/j.zemedi.2008.07.003]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/402999
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact